Your browser doesn't support javascript.
loading
Oral pharmacological treatment of X-linked dystonia parkinsonism: Successes and failures
Philippine Journal of Neurology ; : 79-82, 2012.
Article in English | WPRIM | ID: wpr-633183
ABSTRACT
There is a paucity of published literature on the different oral medications tried for X-linked dystonia parkinsonism (XDP). In practice, most XDP patients are tired on medication typically used for patients with generalized dystonia. These drugs include anticholinergic agents, baclofen, clonazepam and other ben-zodiazepines, tetrabenazine, and clozapine. Although several articles have shown that these classess of drugs are beneficial for patients with generalized dystonia, none been systematically studied specifically for XDP patients. We are currently conducting the first randomized, placebo-controlled trial on the medications that have been used in XDP.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Tetrabenazine / Baclofen / Levodopa / Clonazepam / Clozapine / Cholinergic Antagonists / Parkinsonian Disorders / Dystonic Disorders / Genetic Diseases, X-Linked / Dystonia Type of study: Controlled clinical trial Limits: Humans Language: English Journal: Philippine Journal of Neurology Year: 2012 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Tetrabenazine / Baclofen / Levodopa / Clonazepam / Clozapine / Cholinergic Antagonists / Parkinsonian Disorders / Dystonic Disorders / Genetic Diseases, X-Linked / Dystonia Type of study: Controlled clinical trial Limits: Humans Language: English Journal: Philippine Journal of Neurology Year: 2012 Type: Article